[HTML][HTML] Cytomegalovirus infection after liver transplantation: current concepts and challenges
RR Razonable - World journal of gastroenterology: WJG, 2008 - ncbi.nlm.nih.gov
Cytomegalovirus (CMV) is a common viral pathogen that influences the outcome of liver
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …
transplantation. In addition to the direct effects of CMV syndrome and tissue-invasive …
[HTML][HTML] Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review
HY Sun, MM Wagener, N Singh - American Journal of Transplantation, 2008 - Elsevier
The precise impact of valganciclovir as preventive therapy for cytomegalovirus (CMV) in
solid organ transplant (SOT) recipients is not fully defined. Data from studies using …
solid organ transplant (SOT) recipients is not fully defined. Data from studies using …
[PDF][PDF] Delayed‐onset primary cytomegalovirus disease after liver transplantation
SK Arthurs, AJ Eid, RA Pedersen… - Liver …, 2007 - Wiley Online Library
Clinical practice guidelines recommend antiviral prophylaxis to cytomegalovirus (CMV)
donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the …
donor‐positive/recipient‐negative (D+/R−) liver transplant recipients. We assessed the …
[HTML][HTML] Management of cytomegalovirus infection and disease in liver transplant recipients
J Bruminhent, RR Razonable - World journal of hepatology, 2014 - ncbi.nlm.nih.gov
Cytomegalovirus (CMV) is one of the most common viral pathogens causing clinical disease
in liver transplant recipients, and contributing to substantial morbidity and occasional …
in liver transplant recipients, and contributing to substantial morbidity and occasional …
Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy
AC Kalil, AG Freifeld, ER Lyden, JA Stoner - Plos one, 2009 - journals.plos.org
Background Several anti-viral drugs have demonstrated efficacy in preventing
Cytomegalovirus (CMV) infections in solid organ transplant (SOT) patients. The recently …
Cytomegalovirus (CMV) infections in solid organ transplant (SOT) patients. The recently …
[HTML][HTML] Current concepts on cytomegalovirus infection after liver transplantation
SO Lee, RR Razonable - World journal of hepatology, 2010 - ncbi.nlm.nih.gov
Cytomegalovirus (CMV) is the most common viral pathogen that negatively impacts on the
outcome of liver transplantation. CMV cause febrile illness often accompanied by bone …
outcome of liver transplantation. CMV cause febrile illness often accompanied by bone …
[HTML][HTML] Universal prophylaxis or preemptive strategy for cytomegalovirus disease after liver transplantation: a systematic review and meta-analysis
We systematically reviewed and meta-analyze the efficacy of universal prophylaxis (UP) and
preemptive (PE) strategies (using ganciclovir or valganciclovir) in preventing …
preemptive (PE) strategies (using ganciclovir or valganciclovir) in preventing …
CMV infection, diagnosis and antiviral strategies after liver transplantation
I Lautenschlager - Transplant International, 2009 - Wiley Online Library
Cytomegalovirus (CMV) is a significant pathogen complicating the post‐transplant course of
organ recipients. In liver transplant patients, the febrile clinical illness caused by CMV may …
organ recipients. In liver transplant patients, the febrile clinical illness caused by CMV may …
[PDF][PDF] Valganciclovir as preemptive therapy for cytomegalovirus in cytomegalovirus‐seronegative liver transplant recipients of cytomegalovirus‐seropositive donor …
N Singh, C Wannstedt, L Keyes, D Mayher… - Liver …, 2008 - Wiley Online Library
The efficacy of valganciclovir as preemptive therapy for the prevention of cytomegalovirus
(CMV) disease and its impact on indirect sequelae of CMV were assessed in recipient …
(CMV) disease and its impact on indirect sequelae of CMV were assessed in recipient …
[PDF][PDF] Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens
N Singh, HY Sun - Liver Transplantation, 2008 - Wiley Online Library
The propensity of liver transplant recipients to develop more fulminant disease presentation
and a higher risk of disseminated disease due to a number of opportunistic infections …
and a higher risk of disseminated disease due to a number of opportunistic infections …